Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecule...
Novo Nordisk announced plans to invest more than 42 billion Danish kroner starting in 20231 to expand existing manufacturing facilities in Kalundborg...
Investment of EUR 175 million reaffirms Sandoz commitment to long-term leadership in off-patent medicines New penicillin production process will signifi...
-Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, an...
LumaCyte, a leading innovator in advanced single cell analysis technology and instrumentation, is proud to announce the launch of their newly redesigned fl...
Fluor Corporation announced that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Co...
Sharp, a global leader in commercial pharmaceutical packaging and clinical trial supply services, has today announced the acquisition of Berkshire Ste...
Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation (NYSE:DHR), ...
Thermo Fisher Scientific, the world leader in serving science, today expanded its manufacturing capacity in St. Louis to support biologic therapies for dis...
BIOVECTRA and Acuitas Therapeutics, Inc. announced that they have entered into a technology transfer service agreement under which BIOVECTRA will acc...
According to Cytiva’s 2023 Global Biopharma Resilience Index, the manufacturing of biologics in India is likely to increase over the next three years...
Freudenberg Medical, a leading global design and manufacturing partner for minimally invasive medical devices, has announced the creation of 100 new jobs, ...
Ensovi will leverage Ginkgo Enzyme Services to help optimize its platform for the cell-free transformation of carbon dioxide (CO2) into Acetyl-CoA, which c...
New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...
© 2025 Biopharma Boardroom. All Rights Reserved.
